Effect of Non-Invasive TMS stimulation in patients with ataxia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202503520006049

Enrollment

Registered

2025-03-13

Start date

2025-03-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

Mid cerebellar active stimulation with sham C3

Mid cerebellar active stimulation with active C3

Sham stimulation mid cerebellar and sham C3

Stimulation active 10hz mid cerebellar and C3

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1- Adults 19-50 years 2- Both genders 3- Ambulant Patients with ataxia, with Burg Balance scale above 16

Exclusion criteria

Exclusion criteria: 1-Presence of contraindications to TMS such as pregnancy, epilepsy skull defects, metal implants or pacemaker. 2- Sever ataxia , Burg Balance scale below 16

Design outcomes

Primary

Measure	Time frame
Improvement of the ataxia significant increase of the burg balance scale	—

Secondary

Measure	Time frame
improvement of gait increase velocity of 20 meter walk test ;Improvement of cognition on cerebellar cognitive scale	—

Countries

Egypt

Contacts

Public ContactFatma fathalla

lecturer of neurology faculty of medicine ain shams university

fatma.fathalla@med.asu.edu.eg01128593444

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 10, 2026